Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 3/20 | 1.00 |
| ▸ | AURKA | O14965 | 2/20 | 1.00 |
| ▸ | CHAT | P28329 | 2/20 | 1.00 |
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 1.00 |
| ▸ | KAT5 | Q92993 | 2/20 | 1.00 |
| ▸ | KAT2B | Q92831 | 1/20 | 1.00 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coenzyme_A SCHEMBL29350970 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL18180012 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL13500623 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL26752 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL18682056 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL18682057 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL18675521 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL18033983 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL26753 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 | |
| Coenzyme_A SCHEMBL18811987 | 1.00 | EP300 (1.00) | EP300AURKACHATNAA50KAT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103734-A1 | In Vitro Bioproduction of Polyalkanoates from Polypropylene and Polyethylene | KIMBERLY CLARK CO (US) | 2026-04-16 | — | — | US | claimed |
| EP-3336099-B1 | METHOD FOR SELECTIVELY BINDING CELLS TO A BINDING PARTNER AND DEVICE COMPRISING CELLS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-03-04 | — | — | EP | claimed |
| US-20260015572-A1 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS PRODUCTION OF FATTY ACID DERIVED PRODUCTS THROUGH THE EXPRESSION OF 3-HYDROXYACYL-ACP:COA TRANSACYLASES | LANZATECH INC (US) | 2026-01-15 | — | — | US | claimed |
| EP-4655403-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF NITROGEN-CONTAINING, NON-CARBON COMPOUNDS | Fertis India Pvt Ltd (IN) | 2025-12-03 | — | — | EP | claimed |
| EP-4655386-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF CARBON-CONTAINING NON-NITROGEN COMPOUNDS | Fertis India Pvt Ltd (IN) | 2025-12-03 | — | — | EP | claimed |
| EP-4649136-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF NITROGEN AND CARBON-CONTAINING COMPOUNDS | Fertis India Pvt Ltd (IN) | 2025-11-19 | — | — | EP | claimed |
| US-12391937-B2 | Biosynthesis of products from 1-carbon compounds | MOJIA BIOTECH PTE. LTD. (SG) | 2025-08-19 | — | — | US | claimed |
| EP-4594513-A1 | IN VITRO BIOPRODUCTION OF POLYALKANOATES FROM POLYPROPYLENE AND POLYETHYLENE | Kimberly-Clark Worldwide, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| US-20240319166-A1 | Genetically-encoded volatile synthetic biomarkers for breath-based cancer detection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-09-26 | — | — | US | claimed |
| US-20240309417-A1 | Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals | GONZALEZ RAMON (US) | 2024-09-19 | — | — | US | claimed |
| US-11913049-B2 | Bioconversion of short-chain hydrocarbons to fuels and chemicals | Gonzalez, Ramon (US) | 2024-02-27 | — | — | US | claimed |
| US-20240060100-A1 | PROCESSES FOR PRODUCTION OF ALKYLATED FATTY ACIDS AND DERIVATIVES THEREOF | ExxonMobil Technology and Engineering Company | 2024-02-22 | — | — | US | claimed |
| EP-4305173-A1 | RECOMBINANT MICROORGANISMS AND USES THEREFOR | Lanzatech, Inc. (US) | 2024-01-17 | — | — | EP | claimed |
| US-11857532-B2 | Treatment and prediction of therapeutic responses in patients suffering from Friedreich ataxia | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2024-01-02 | — | — | US | claimed |
| WO-2022192865-A9 | RECOMBINANT MICROORGANISMS AND USES THEREFOR | LANZATECH, INC. (US) | 2023-02-09 | — | — | WO | claimed |
| WO-2022192865-A1 | RECOMBINANT MICROORGANISMS AND USES THEREFOR | LANZATECH, INC. (US) | 2022-09-15 | — | — | WO | claimed |
| US-20220282289-A1 | RECOMBINANT MICROORGANISMS AND USES THEREFOR | UNITED STATES DEPARTMENT OF ENERGY | 2022-09-08 | — | — | US | claimed |
| US-20220112477-A1 | BIOSYNTHESIS OF PRODUCTS FROM 1-CARBON COMPOUNDS | MOJIA BIOTECH PTE. LTD. (SG) | 2022-04-14 | — | — | US | claimed |
| US-20220105073-A1 | TREATMENT AND PREDICTION OF THERAPEUTIC RESPONSES IN PATIENTS SUFFERING FROM FRIEDREICH ATAXIA | UNIVERSITÉ PARIS CITÉ (FR) | 2022-04-07 | — | — | US | claimed |
| CN-107429271-B | Biosynthesis of products from monocarbon compounds | R·冈萨雷斯 | 2022-03-04 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015572-A1 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS PRODUCTION OF FATTY ACID DERIVED PRODUCTS THROUGH THE EXPRESSION OF 3-HYDROXYACYL-ACP:COA TRANSACYLASES | COASY, FADS2, FADS1 | EP300 1174/4885AURKA 2427/4885CHAT 1822/4885 |
| US-20260103734-A1 | In Vitro Bioproduction of Polyalkanoates from Polypropylene and Polyethylene | ALKBH3, CES2, FTO | EP300 1769/4885AURKA 4163/4885CHAT 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.